Vagus nerve stimulation reduced inflammation and restored cognitive function after injury
For adults over age 65, surgical complications can dampen not only their physical health but also their mental sharpness, with more than half of high-risk cases declining into delirium.
In research published this week in the journal Brain Stimulation, Duke University scientists show in a mouse model that a current treatment for seizures can also reverse brain inflammation, such as inflammation after surgery, and the subsequent confusion or cognitive decline that results.
The therapy involves minimally invasive stimulation of the vagus nerve using small electrical pulses comparable to a cell phone’s vibrations.
The scientists used a Doppler ultrasound to guide the placement of a needle that delivers the electrical pulse, avoiding nearby delicate structures such as the carotid artery. Researchers hope to refine the technique into a completely non-invasive approach to preventing cognitive decline when seniors and other at-risk patients have surgery.
“Delirium is now recognized as the most common complication in older adults after surgery,” said Niccolò Terrando, Ph.D., associate professor of anesthesiology at Duke and the study’s senior author. “For most patients, it lasts a few days and resolves on its own. For some, it can lead to severe complications and even contribute to long lasting cognitive deficits, like dementia.”
Terrando noted that these cognitive complications have a huge impact on quality of life and can be expensive, with health care costs for delirium reaching $164 billion a year according to the American Society of Anesthesiologists.
“So far, there is no therapy for this kind of cognitive complication after surgery,” Terrando said. Anti-inflammatory drugs have many side effects and work broadly, he said, and they don’t adequately target the inflammation in the brain that scientists believe triggers cognitive complications.
The vagus nerve helps the brain communicate with the heart, lungs, gut and other parts of the body. Vagus nerve stimulators have been surgically implanted in epilepsy patients for more than 20 years to reduce seizures.
In recent years, U.S. doctors have also prescribed at-home, non-invasive stimulators for severe headaches. However, there is not substantial evidence that the devices are stimulating the vagus nerve and not other structures near it, said Warren M. Grill, Ph.D., professor of biomedical engineering at Duke.
For the experimental model, mice with inflammation received one nerve-stimulating treatment lasting several minutes. The researchers monitored for signs of vagus nerve activation, such as a slower heart rate and twitching of muscles around the larynx, and found improved cognitive outcomes and reduced brain inflammation after this treatment.
“This minimally invasive approach is already exceedingly benign, but in the long term it would be desirable to have an entirely non-invasive approach and we are beginning that work,” Grill said.
The Latest on: Vagus nerve stimulation
via Google News
The Latest on: Vagus nerve stimulation
- Vibration stimulation of external ear alleviates inflammation in RA on April 17, 2019 at 1:24 pm
“Transcutaneous auricular vagus nerve stimulation (taVNS) is an investigational therapy in which electrical signals are applied to the cutaneous territory supplied by the auricular branch of the vagus ... […]
- Neuromodulation Market is Anticipated to Grow US$ 13.0 Billion by 2024 on April 17, 2019 at 5:08 am
Spinal Cord Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation & Other Neuromodulation Technologies. External neuromodulation its covers Transcranial Magnetic Stimulation & Transcutaneous ... […]
- Non-invasive vagus nerve stimulation shows promise for treatment of rheumatoid arthritis on April 16, 2019 at 5:32 pm
MANHASSET, NY, April 16, 2019 /PRNewswire/ -- Bioelectronic medicine scientists at The Feinstein Institute for Medical Research collaborated with counterparts from Academic Medical Center at ... […]
- Neurostimulation Devices Market 2019 Global Demand Overview, Growth Insights By Size and Share Estimation to 2022 on April 16, 2019 at 3:28 am
Cyberonics: Cyberonics, U.S. headquartered medical device manufacturing company. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy system which has approved by FDA. They ... […]
- UAB patient first in Alabama to get deep brain stimulation for epilepsy on April 11, 2019 at 11:06 am
Deep brain stimulation has long been used to treat Parkinson’s ... DBS is not the only technology that uses neurostimulation to treat epilepsy. VNS stimulates the vagus nerve in the neck and does not ... […]
- Good vibrations to treat inflammatory arthritis on April 3, 2019 at 12:07 pm
Ultrasound stimulation of the vagus nerve via the spleen triggers the neural-immune reflex to dampen inflammatory arthritis. Can vibrating your spleen relieve those achy knees? The cholinergic ... […]
- Global Neurostimulation Devices Market Will Reach USD 15,404 Million By 2025: Zion Market Research on April 3, 2019 at 5:54 am
spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and others. Spinal cord stimulation devices dominated the market in 2018 and are likely to show the ... […]
- Discover the Vagus Nerve Stimulator Lucrative Opportunities by 2028 on March 23, 2019 at 3:05 pm
Valley Cottage, NY -- (SBWIRE) -- 03/23/2019 -- Of the total global population inflicted by neurological disorders, approximately 50% suffers from an epileptic disorder, research and surveys say. ... […]
- Vagus Nerve Stimulator Market: Forecast Factors & Relevance of impact, Technology Assessment and Opportunity Assessment 2018-2028 on March 11, 2019 at 8:11 am
A recent market study published by FMI Vagus Nerve Stimulator Market: Global Industry Analysis 2013 2017 and Opportunity Assessment 2018 2028 consists a comprehensive assessment of the most important ... […]
via Bing News